Related Experiment Video
Updated: Feb 5, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Polypyridyl Zinc(II)-Indomethacin Complexes with Potent Anti-Breast Cancer Stem Cell Activity
Tiffany K Rundstadler1, Arvin Eskandari2, Sarah M Norman3
1Department of Chemistry, King's College London, London SE1 1DB, UK. tiffany.rundstadler@etu.unistra.fr.
Abstract:
Cancer stem cells (CSCs) are thought of as a clinically pertinent subpopulation of tumors, partly responsible for cancer relapse and metastasis. Research programs aimed at discovering anti-CSC agents have largely focused on biologics and purely organic molecules. Recently, we showed that a family of redox-active copper(II) complexes with phenanthroline-based ligands and nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin, are capable of potently and selectively killing breast CSCs. Herein we present analogous redox-inactive, zinc(II)-phenanthroline-indomethacin complexes with the ability to kill breast CSCs and bulk breast cancer cells with equal potency (in the submicro- or micromolar range). A single dose of the zinc(II) complexes could theoretically be administered to eliminate whole tumor populations. Excitingly, some of the zinc(II) complexes decrease the growth and viability of mammospheres to a comparable or higher degree than salinomycin, a compound known to effectively kill breast CSCs. As far as we are aware this is the first report to examine the anti-breast CSC activity of zinc(II)-containing compounds.
Insights
New zinc(II) complexes show potent anti-cancer activity. These compounds effectively target both cancer stem cells (CSCs) and bulk tumor cells, offering a promising strategy for complete tumor elimination.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Nanotechnology
Background:
- Cancer stem cells (CSCs) drive tumor relapse and metastasis.
- Current anti-CSC therapies often focus on biologics or organic molecules.
- Previous research highlighted copper(II) complexes for selective CSC targeting.
Purpose of the Study:
- To investigate the anti-cancer efficacy of novel redox-inactive zinc(II) complexes.
- To evaluate the potential of these zinc(II) compounds against breast CSCs and bulk cancer cells.
- To compare the activity of zinc(II) complexes with established CSC-targeting agents like salinomycin.
Main Methods:
- Synthesis and characterization of zinc(II)-phenanthroline-indomethacin complexes.
- In vitro assessment of cytotoxicity against breast CSCs and bulk breast cancer cells.
- Evaluation of mammosphere formation and viability assays.
Main Results:
- Zinc(II) complexes demonstrated potent cytotoxicity against both breast CSCs and bulk cancer cells.
- The compounds exhibited efficacy in the submicromolar to micromolar range.
- Some zinc(II) complexes matched or surpassed salinomycin in reducing mammosphere growth and viability.
Conclusions:
- Redox-inactive zinc(II) complexes are effective against breast CSCs and bulk tumor cells.
- These zinc(II) compounds represent a novel therapeutic strategy for eliminating entire tumor populations.
- This study is the first to report on the anti-breast CSC activity of zinc(II)-containing compounds.
Related Concept Videos
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adult Stem Cells
Embryonic Stem Cells
Induced Pluripotent Stem Cells
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...

